The low PDS5B expression may be regulated by epigenetic modifications, especially methylation, of CpG island of PDS5B promoter [226], and PDS5B reduction might promote cancer cell proliferation through the IL-6/STAT3/cyclin D axis [227]. The gene discussed is PDS5B; the disease is cancer.